John S. Lazo graduated from Johns Hopkins University and received his Ph.D. in pharmacology from the University of Michigan. He was a postdoctoral fellow and faculty member at Yale University until his appointment as Allegheny Foundation professor and chairman of Department of Pharmacology at University of Pittsburgh, a position he held for 17 years before becoming the first director of its Drug Discovery Institute.
In 2011, Lazo become the Harrison Distinguished Teaching Professor and associate dean for basic research at the University of Virginia. Currently he is the associate director for basic research for the Cancer Center. His primarily research focus is on the mechanism of action of novel drugs, particularly anticancer agents, and on the fundamental biological role of protein tyrosine phosphatases.
Lazo has published 360 scientific articles and holds 10 U.S.-issued patents. He is an elected Fellow of the American Association for the Advancement of Science. He has been on the Board of Directors for the American Association for Cancer Research, president for the American Society for Pharmacology and Experimental Therapeutics, and member of the Board of the Carnegie Museum of Natural History. He has mentored 15 Ph.D. students and 31 postdoctoral fellows. He co-founded several early stage biopharmaceutical companies.
Related SLAS Reading Undruggable or Just Undrugged? Exploring Alternative Targets (SLAS Electronic Laboratory Neighborhood)
SLAS publishes two MEDLINE-indexed journals and accepts manuscripts on an ongoing basis from members and non-members. > READ MORE
September 29, 2017